Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 5/2010

01-10-2010 | Journal club critique

Clostridium difficile: moving beyond antimicrobial therapy

Authors: Amesh A Adalja, John A Kellum

Published in: Critical Care | Issue 5/2010

Login to get access

Excerpt

Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, Gerding DN, Nichol G, Thomas WD Jr, Leney M, Sloan S, Hay CA, Ambrosino DM: Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 2010, 362:197-205. …
Literature
1.
Dubberke ER, Butler AM, Reske KA, Agniel D, Olsen MA, D'Angelo G, McDonald LC, Fraser VJ: Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis 2008, 14: 1031-1038. 10.3201/eid1407.070867PubMedCentralCrossRefPubMed
2.
Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ: Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 2008, 46: 497-504. 10.1086/526530CrossRefPubMed
3.
Garey KW, Sethi S, Yadav Y, DuPont HL: Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect 2008, 70: 298-304. 10.1016/j.jhin.2008.08.012CrossRefPubMed
4.
Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, Gerding DN, Nichol G, Thomas WD Jr, Leney M, Sloan S, Hay CA, Ambrosino DM: Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 2010, 362: 197-205. 10.1056/NEJMoa0907635CrossRefPubMed
5.
Kyne L: Clostridium difficile--beyond antibiotics. N Engl J Med 2010, 362: 264-265. 10.1056/NEJMe0910055CrossRefPubMed
Metadata
Title
Clostridium difficile: moving beyond antimicrobial therapy
Authors
Amesh A Adalja
John A Kellum
Publication date
01-10-2010
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2010
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc9249

Other articles of this Issue 5/2010

Critical Care 5/2010 Go to the issue

Letter

Direct antimicrobial activity of antithrombin?

Review

Clinical review: mechanical circulatory support for cardiogenic shock complicating acute myocardial infarction

Commentary

Septic-associated encephalopathy - everything starts at a microlevel

Review

Bench-to-bedside review: Circulating microparticles - a new player in sepsis?

Research

Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units

Commentary

Estimation of dead space fraction can be simplified in the acute respiratory distress syndrome